Gastric-cancer spheroid assays demonstrate that nightly (but not daytime) melatonin pulses synchronise T-cell NAD+ oscillations, sharpen granzyme-B release and restrain tumour growth—an effect abrogated in BMAL1-knockout mice (54). The gene discussed is BMAL1; the disease is neoplasm.